BACKGROUND: Left ventricular ejection fraction (EF) is an independent predictor of adverse outcomes after myocardial infarction (MI). However, current data on trajectories and determinants of EF are scarce. The present study aimed to describe the epidemiology of EF after MI. METHODS: Data from a single-center prospectively-designed registry of consecutive patients hospitalized at a large tertiary cardiology center were utilized. RESULTS: Out of 1,593 patients in the registry, 1,065 were hospitalized for MI type I (65.4% STEMI) and had no previous history of heart failure or MI. At discharge, EF < 40% was present in 238 (22.3%), EF 40-50% in 326 (30.6%) and EF > 50% in 501 (47.0%). Patients with EF < 40% were often those who suffered subacute and anterior STEMI, had higher heart rate at admission and higher maximal troponin level, and had more often HF signs requiring intravenous diuretics. Among subjects with EF < 40%, the follow-up EF was available in 166 (80% of eligible). Systolic function recovered to EF > 50% in 39 (23.1%), slightly improved to EF 40-50% in 44 (26.0%) and remained below 40% in 86 (50.9%). Systolic function improvement to EF > 40% was predicted by lower severity of coronary atherosclerosis, lower leukocyte count, and the absence of atrial fibrillation. CONCLUSIONS: Despite recent improvements in in-hospital MI care, one in five patients has systolic dysfunction at hospital discharge. Out of these, EF improves in 51%, and full recovery is observed in 23%. The severity of coronary atherosclerosis, inflammatory response to MI, and atrial fibrillation may affect EF recovery.

1st Medical School Charles University Prague Czechia

3rd Medical School Charles University Prague Czechia

Department of Cardiology Institute for Clinical and Experimental Medicine Prague Czechia

Department of Preventive Cardiology Institute for Clinical and Experimental Medicine Prague Czechia

Medical and Dentistry School Palacký University Olomouc Czechia

Zobrazit více v PubMed

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. . 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. (2017) 39:119–77. 10.1093/eurheartj/ehx393 PubMed DOI

Ng VG, Lansky AJ, Meller S, Witzenbichler B, Guagliumi G, Peruga JZ, et al. . The prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. Eur Heart J Acute ular Care. (2014) 3:67–77. 10.1177/2048872613507149 PubMed DOI PMC

Multicenter Postinfarction Research Group . Risk stratification and survival after myocardial infarction. N Engl J Med. (1983) 309:331–6. 10.1056/NEJM198308113090602 PubMed DOI

Rouleau JL, Talajic M, Sussex B, Potvin L, Warnica W, Davies RF, et al. . Myocardial infarction patients in the 1990s–their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol. (1996) 27:1119–27. 10.1016/0735-1097(95)00599-4 PubMed DOI

Exner DV, Kavanagh KM, Slawnych MP, Mitchell LB, Ramadan D, Aggarwal SG, et al. . Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol. (2007) 50:2275–84. 10.1016/j.jacc.2007.08.042 PubMed DOI

Chew DS, Heikki H, Schmidt G, Kavanagh KM, Dommasch M, Bloch Thomsen PE, et al. . Change in Left Ventricular Ejection Fraction Following First Myocardial Infarction and Outcome. JACC Clin Electrophysiol. (2018) 4:672–82. 10.1016/j.jacep.2017.12.015 PubMed DOI

Chew DS, Wilton SB, Kavanagh K, Southern DA, Tan-Mesiatowsky LE, Exner DV. Left ventricular ejection fraction reassessment post–myocardial infarction: Current clinical practice and determinants of adverse remodeling. Am Heart J. (2018) 198:91–6. 10.1016/j.ahj.2017.11.014 PubMed DOI

Parodi G, Memisha G, Carrabba N, Signorini U, Migliorini A, Cerisano G, et al. . Prevalence, predictors, time course, and long-term clinical implications of left ventricular functional recovery after mechanical reperfusion for acute myocardial infarction. Am J Cardiol. (2007) 100:1718–22. 10.1016/j.amjcard.2007.07.022 PubMed DOI

Wu WY, Biery DW, Singh A, Divakaran S, Berman AN, Ayuba G, et al. . Recovery of left ventricular systolic function and clinical outcomes in young adults with myocardial infarction. J Am Coll Cardiol. (2020) 75:2804–15. 10.1016/j.jacc.2020.03.074 PubMed DOI PMC

Wohlfahrt P, Nativi-Nicolau J, Zhang M, Selzman CH, Greene T, Conte J, et al. . Quality of life in patients with heart failure with recovered ejection fraction. JAMA Cardiol. (2021) 6:957–62. 10.1001/jamacardio.2021.0939 PubMed DOI PMC

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. . 2021 ESC Guidelines for the diagnosis treatment of acute chronic heart failure: Developed by the Task Force for the diagnosis treatment of acute chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. (2021) 42:3599–726. 10.1093/eurheartj/ehab368 PubMed DOI

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. . 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. (2022) 145:e895–e1032. 10.1161/CIR.0000000000001073 PubMed DOI

Szummer K, Wallentin L, Lindhagen L, Alfredsson J, Erlinge D, Held C, et al. . Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014. Eur Heart J. (2017) 38:3056–65. 10.1093/eurheartj/ehx515 PubMed DOI PMC

Szummer K, Wallentin L, Lindhagen L, Alfredsson J, Erlinge D, Held C, et al. . Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014. Eur Heart J. (2018) 39:3766–76. 10.1093/eurheartj/ehy554 PubMed DOI

Gensini GG, A. more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. (1983) 51:606. 10.1016/S0002-9149(83)80105-2 PubMed DOI

Rampidis GP, Benetos G, Benz DC, Giannopoulos AA, Buechel RR. A guide for Gensini Score calculation. Atherosclerosis. (2019) 287:181–3. 10.1016/j.atherosclerosis.2019.05.012 PubMed DOI

Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E, et al. . A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J. (2002) 23:1190–201. 10.1053/euhj.2002.3193 PubMed DOI

Danchin N, Vaur L, Genès N, Renault M, Ferrières J, Etienne S, et al. . Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results. J Am Coll Cardiol. (1997) 30:1598–605. 10.1016/S0735-1097(97)00371-9 PubMed DOI

Hanania G, Cambou JP, Guéret P, Vaur L, Blanchard D, Lablanche JM, et al. . Management and in-hospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century: results from the French nationwide USIC 2000 registry. Heart. (2004) 90:1404–10. 10.1136/hrt.2003.025460 PubMed DOI PMC

Magnesium in Coronaries (MAGIC) Trial Investigators . Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. Lancet. (2002) 360:1189–96. 10.1016/S0140-6736(02)11278-5 PubMed DOI

Shlipak MG, Browner WS, Noguchi H, Massie B, Frances CD, McClellan M. Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction. Am J Med. (2001) 110:425–33. 10.1016/S0002-9343(01)00652-0 PubMed DOI

Møller JE, Brendorp B, Ottesen M, Køber L, Egstrup K, Poulsen SH, et al. . Congestive heart failure with preserved left ventricular systolic function after acute myocardial infarction: clinical and prognostic implications. Eur J Heart Fail. (2003) 5:811–9. 10.1016/S1388-9842(03)00159-4 PubMed DOI

Rott D, Behar S, Hod H, Feinberg MS, Boyko V, Mandelzweig L, et al. . Improved survival of patients with acute myocardial infarction with significant left ventricular dysfunction undergoing invasive coronary procedures. Am Heart J. (2001) 141:267–76. 10.1067/mhj.2001.111545 PubMed DOI

Ottervanger JP, Van't Hof AWJ, Reiffers S, Hoorntje JCA, Suryapranata H, de Boer MJ, et al. . Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J. (2001) 22:785–90. 10.1053/euhj.2000.2316 PubMed DOI

Salomaa V, Ketonen M, Koukkunen H, Immonen-Räihä P, Jerkkola T, Kärjä-Koskenkari P, et al. . Decline in out-of-hospital coronary heart disease deaths has contributed the main part to the overall decline in Coronary Heart Disease mortality rates among persons 35 to 64 years of age in Finland. Circulation. (2003) 108:691–6. 10.1161/01.CIR.0000083720.35869.CA PubMed DOI

Dudas K, Lappas G, Stewart S, Rosengren A. Trends in out-of-hospital deaths due to coronary heart disease in Sweden (1991 to 2006). Circulation. (2011) 123:46–52. 10.1161/CIRCULATIONAHA.110.964999 PubMed DOI

Movahed MR, Hashemzadeh M, Jamal MM, Ramaraj R. Decreasing in-hospital mortality of patients undergoing percutaneous coronary intervention with persistent higher mortality rates in women and minorities in the United States. J Invasive Cardiol. (2010) 22:58–60. PubMed

Chacko L, Howard JP, Rajkumar C, Nowbar AN, Kane C, Mahdi D, et al. . Effects of percutaneous coronary intervention on death and myocardial infarction stratified by stable and unstable coronary artery disease: a meta-analysis of randomized controlled trials. Circ Cardiovasc Qual Outcomes. (2020) 13:e006363. 10.1161/CIRCOUTCOMES.119.006363 PubMed DOI PMC

Puymirat E, Simon T, Cayla G, Cottin Y, Elbaz M, Coste P, et al. . Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015. Circulation. (2017) 136:1908–19. 10.1161/CIRCULATIONAHA.117.030798 PubMed DOI

Rogers WJ, Frederick PD, Stoehr E, Canto JG, Ornato JP, Gibson CM, et al. . Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J. (2008) 156:1026–34. 10.1016/j.ahj.2008.07.030 PubMed DOI

Oh PC, Choi IS, Ahn T, Moon J, Park Y, Seo JG, et al. . Predictors of recovery of left ventricular systolic dysfunction after acute myocardial infarction: from the korean acute myocardial infarction registry and korean myocardial infarction registry. Korean Circ J. (2013) 43:527–33. 10.4070/kcj.2013.43.8.527 PubMed DOI PMC

Sjöblom J, Muhrbeck J, Witt N, Alam M, Frykman-Kull V. Evolution of left ventricular ejection fraction after acute myocardial infarction: implications for implantable cardioverter-defibrillator eligibility. Circulation. (2014) 130:743–8. 10.1161/CIRCULATIONAHA.114.009924 PubMed DOI

Pfeffer MA, Claggett B, Lewis EF, Granger CB, Køber L, Maggioni AP, et al. . Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. N Engl J Med. (2021) 385:1845–55. 10.1056/NEJMx210024 PubMed DOI

Halade GV, Lee DH. Inflammation and resolution signaling in cardiac repair and heart failure. EBioMedicine. (2022) 79:103992. 10.1016/j.ebiom.2022.103992 PubMed DOI PMC

Ong SB, Hernández-Reséndiz S, Crespo-Avilan GE, Mukhametshina RT, Kwek XY, Cabrera-Fuentes HA, et al. . Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther. (2018) 186:73–87. 10.1016/j.pharmthera.2018.01.001 PubMed DOI PMC

Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. . Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. (2017) 377:1119–31. 10.1056/NEJMoa1707914 PubMed DOI

Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. . Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. (2019) 381:2497–505. 10.1056/NEJMoa1912388 PubMed DOI

Angeli F, Reboldi G, Garofoli M, Ramundo E, Poltronieri C, Mazzotta G, et al. . Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis. Curr Cardiol Rep. (2012) 14:601–10. 10.1007/s11886-012-0289-3 PubMed DOI

Börschel CS, Schnabel RB. The imminent epidemic of atrial fibrillation and its concomitant diseases - myocardial infarction and heart failure - a cause for concern. Int J Cardiol. (2019) 287:162–73. 10.1016/j.ijcard.2018.11.123 PubMed DOI PMC

Stojadinović P, Deshraju A, Wichterle D, Fukunaga M, Peichl P, Kautzner J, et al. . The hemodynamic effect of simulated atrial fibrillation on left ventricular function. J Cardiovasc Electrophysiol. (2022). 10.1111/jce.15669 [Epub ahead of print]. PubMed DOI

Kewcharoen J, Trongtorsak A, Thangjui S, Kanitsoraphan C, Prasitlumkum N. Female gender is associated with an increased left ventricular ejection fraction recovery in patients with heart failure with reduced ejection fraction. Med Sci. (2022) 10:21. 10.3390/medsci10020021 PubMed DOI PMC

Pullen AB, Kain V, Serhan CN, Halade GV. Molecular and cellular differences in cardiac repair of male and female mice. J Am Heart Assoc. (2020) 9:e015672. 10.1161/JAHA.119.015672 PubMed DOI PMC

McGowan JH, Cleland JG. Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods. Am Heart J. (2003) 146:388–97. 10.1016/S0002-8703(03)00248-5 PubMed DOI

Soluble endoglin reflects endothelial dysfunction in myocardial infarction patients: a retrospective observational study

Remote Heart Failure Symptoms Assessment After Myocardial Infarction Identifies Patients at Risk for Death

Attenuation of Hypocretin/Orexin Signaling Is Associated With Increased Mortality After Myocardial Infarction